Pseudo Perfusion of Chinese Hamster Ovary (CHO) Cells as a Reliable Platform for Data Generation to Model and Guide Continuous Perfusion Biomanufacturing
Biotechnology and Bioengineering · 2026-06 · 123 (6) · 1544-1557
DOI: 10.1002/bit.70190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 21.03.2026. Verfasst von Nikola G Malinov und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, Delaware, USA. Hauptthemen laut MEDLINE: Bioreactors, Antibodies, Monoclonal, Cell Culture Techniques, Perfusion. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: U.S. Food and Drug Administration (FDA), Advanced Mammalian Biomanufacturing Innovation Center (AMBIC).
Abstract (Originalsprache)
Chinese Hamster Ovary (CHO) cell monoclonal antibody (mAb) production in continuous perfusion has witnessed a renewed interest within the biopharmaceutical industry. Widespread implementation of perfusion biomanufacturing, however, remains hindered by long process development timelines and high costs. Use of predictive scale‐down platforms to generate large informative metabolic datasets and guide process development decisions is critical to decreasing a molecule's time to market. While scale‐down platforms based on the pseudo perfusion concept have been previously reported, they have not been rigorously validated. They are often limited by oxygen transport or insufficient metabolic characterization, reducing their role to a preliminary screening tool. Here, we report the design and validation of a pseudo perfusion platform based on a phenotype‐driven approach to ascertain that the process emulates continuous perfusion characteristics and is not oxygen limited. Beyond metabolic and cell size steady state, we show that our pseudo perfusion design enables cell cycle subpopulation and intracellular antibody expression steady state. We also demonstrate that pseudo perfusion robustly predicts amino acid demands in continuous perfusion bioreactors with exceptional linear correlation across a broad range of cell‐specific perfusion rates. When coupling the pseudo perfusion platform developed here with a workflow for metabolic characterization, we significantly augment the dimensionality and reliability of data which can be generated at this scale to gain actionable insights towards perfusion process design, ultimately reducing process development timelines and the associated costs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, Delaware, USA.
- Delaware Biotechnology Institute, Department of Biological Sciences, University of Delaware, Newark, Delaware, USA.
ORCID-Profile: Nikola G Malinov, Shivam Barodiya, Marianthi G Ierapetritou, Eleftherios T Papoutsakis
Förderung
- U.S. Food and Drug Administration (FDA)
- Advanced Mammalian Biomanufacturing Innovation Center (AMBIC)
Zitieren
APA
Malinov, N. G., Barodiya, S., Ierapetritou, M. G., & Papoutsakis, E. T. (2026). Pseudo Perfusion of Chinese Hamster Ovary (CHO) Cells as a Reliable Platform for Data Generation to Model and Guide Continuous Perfusion Biomanufacturing. Biotechnology and Bioengineering, 123(6), 1544-1557. https://doi.org/10.1002/bit.70190
Vancouver
Malinov NG, Barodiya S, Ierapetritou MG, Papoutsakis ET. Pseudo Perfusion of Chinese Hamster Ovary (CHO) Cells as a Reliable Platform for Data Generation to Model and Guide Continuous Perfusion Biomanufacturing. Biotechnology and Bioengineering. 2026;123(6):1544-1557. doi:10.1002/bit.70190
BibTeX
@article{Malinov2026,
author = {Malinov, Nikola G and Barodiya, Shivam and Ierapetritou, Marianthi G and Papoutsakis, Eleftherios T},
title = {Pseudo Perfusion of Chinese Hamster Ovary (CHO) Cells as a Reliable Platform for Data Generation to Model and Guide Continuous Perfusion Biomanufacturing},
journal = {Biotechnology and Bioengineering},
year = {2026},
volume = {123},
number = {6},
pages = {1544--1557},
doi = {10.1002/bit.70190}
}
EUVIMED